Log in
NYSEARCA:JIGB

JPMorgan Corporate Bond Research Enhanced ETF Stock Forecast, Price & News

$56.88
-0.19 (-0.33 %)
(As of 10/22/2020 12:00 AM ET)
Add
Today's Range
$56.88
Now: $56.88
$56.88
50-Day Range
$56.78
MA: $57.24
$57.71
52-Week Range
$47.78
Now: $56.88
$59.36
Volume73 shs
Average Volume3,834 shs
Market Capitalization$42.66 million
P/E RatioN/A
Dividend Yield3.05%
BetaN/A

Geographic Exposure of JIGB

Currency Exposure of JIGB

Sector Exposure of JIGB

Industry Exposure of JIGB

Basic Details

Issuer JPMorgan
Fund NameJPMorgan Corporate Bond Research Enhanced ETF
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:JIGB
Inception Date12/12/2018
Fund ManagerLisa Coleman, Lorenzo Napolitano, Bhupinder Bahra, Frederick Bourgoin, Sameer Iqbal
WebN/A
PhoneN/A

Fund Focus

Asset ClassFixed Income
Benchmark
CategoryCorporate
FocusInvestment Grade
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$42.68 million
Average Daily Volume$1,091.00
Discount/Premium0.11%

ETF Expenses

Management Fee0.14%
Other Expenses0.27%
Total Expenses0.41%
Fee Waiver-0.27%
Net Expenses0.14%

Administrator, Advisor and Custodian

AdministratorJPMIM
AdvisorJPMIM
CustodianJPMorgan Chase Bank, N.A.
DistributorJPMorgan Distribution Services, Inc.
Transfer AgentJPMorgan Chase Bank, N.A.
Trustee
Lead Market Maker
$56.88
-0.19 (-0.33 %)
(As of 10/22/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive JIGB News and Ratings via Email

Sign-up to receive the latest news and ratings for JIGB and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











JPMorgan Corporate Bond Research Enhanced ETF (NYSEARCA:JIGB) Frequently Asked Questions

How has JPMorgan Corporate Bond Research Enhanced ETF's stock been impacted by COVID-19 (Coronavirus)?

JPMorgan Corporate Bond Research Enhanced ETF's stock was trading at $54.04 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, JIGB shares have increased by 5.3% and is now trading at $56.8805.
View which stocks have been most impacted by COVID-19
.

How often does JPMorgan Corporate Bond Research Enhanced ETF pay dividends? What is the dividend yield for JPMorgan Corporate Bond Research Enhanced ETF?

JPMorgan Corporate Bond Research Enhanced ETF announced a monthly dividend on Friday, January 31st. Stockholders of record on Monday, February 3rd will be paid a dividend of $0.1461 per share on Wednesday, February 5th. This represents a $1.75 dividend on an annualized basis and a dividend yield of 3.08%. The ex-dividend date is Friday, January 31st.
View JPMorgan Corporate Bond Research Enhanced ETF's dividend history
.

What other stocks do shareholders of JPMorgan Corporate Bond Research Enhanced ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other JPMorgan Corporate Bond Research Enhanced ETF investors own include ABIOMED (ABMD), Catalent (CTLT), Hologic (HOLX), Merck & Co., Inc. (MRK), Net Element (NETE), Novavax (NVAX), Quanterix (QTRX), Arca Biopharma (ABIO), AbbVie (ABBV) and Audioeye (AEYE).

What is JPMorgan Corporate Bond Research Enhanced ETF's stock symbol?

JPMorgan Corporate Bond Research Enhanced ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "JIGB."

How do I buy shares of JPMorgan Corporate Bond Research Enhanced ETF?

Shares of JIGB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is JPMorgan Corporate Bond Research Enhanced ETF's stock price today?

One share of JIGB stock can currently be purchased for approximately $56.88.

How big of a company is JPMorgan Corporate Bond Research Enhanced ETF?

JPMorgan Corporate Bond Research Enhanced ETF has a market capitalization of $42.66 million.

This page was last updated on 10/23/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.